Nuveen Asset Management, LLC Acadia Pharmaceuticals Inc Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,347,093 shares of ACAD stock, worth $34.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,347,093
Previous 1,362,985
1.17%
Holding current value
$34.3 Million
Previous $21 Million
17.84%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding ACAD
# of Institutions
345Shares Held
165MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.09 Billion9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$388 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$307 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$229 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$157 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $4.12B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...